Page last updated: 2024-10-26

valproic acid and 22q11.2 Deletion Syndrome

valproic acid has been researched along with 22q11.2 Deletion Syndrome in 2 studies

Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, Z1
Yu, R1
Dun, K1
Burke, J1
Caplin, N1
Greenaway, T1
Alla, P1
Philip, N1
Azulay, JP1
Attarian, S1
Pouget, J1

Other Studies

2 other studies available for valproic acid and 22q11.2 Deletion Syndrome

ArticleYear
22q11.2 deletion presenting with severe hypocalcaemia, seizure and basal ganglia calcification in an adult man.
    Internal medicine journal, 2011, Volume: 41, Issue:1a

    Topics: Adult; Age of Onset; Anticonvulsants; Basal Ganglia; Brain; Calcinosis; Chromosome Deletion; Chromos

2011
[Epilepsy in an adult with chromosome 22q11 micro-deletion].
    Revue neurologique, 1999, Volume: 155, Issue:11

    Topics: Adult; Anticonvulsants; Atrophy; Brain; Chromosome Deletion; Chromosomes, Human, Pair 22; DiGeorge S

1999